• Adipose-Neural Axis Drives Cardiac Arrhythmias via NPY Signa

  2026-07-13

  Fan et al. (2024) establish a stem cell-based coculture model revealing how the adipose-neural axis, particularly leptin and neuropeptide Y (NPY) signaling, contributes to epicardial adipose tissue–related cardiac arrhythmias. These findings highlight new mechanistic targets and experimental models for dissecting arrhythmogenesis at the neuro-adipose interface.

• Firefly Luciferase mRNA (5-moUTP): Advanced Reporter Workflo

  2026-07-13

  Leverage 5-moUTP modified Firefly Luciferase mRNA for robust, immune-silent reporter assays that surpass conventional mRNA tools. This guide unpacks workflow enhancements, troubleshooting, and practical integration with emerging delivery platforms—highlighting the unique advantages of APExBIO’s innovation for translational and immunological research.

• HSP70 Modulates TDP-43 Nuclear Condensation in Poly-PR Stres

  2026-07-12

  Agnihotri et al. elucidate how C9ORF72 poly-PR dipeptide stress drives NEAT1-dependent TDP-43 nuclear condensate formation, with HSP70 activity critically regulating their phase behavior. This work advances our understanding of molecular chaperone involvement in ALS pathogenesis and offers a mechanistic basis for targeting HSP70 in related research.

• Stat3 and NF-κB Mediate Fyn-Driven Neurodegeneration in Zebr

  2026-07-10

  This study establishes that constitutive Fyn kinase activation in zebrafish leads to dopaminergic neuron loss and microglia-driven inflammation via Stat3 and NF-κB pathways. The findings clarify the signaling mechanisms underlying neurodegeneration relevant to Parkinson’s disease and provide a framework for pathway-targeted research.

• Triacetin in Translational Research: Mechanistic Rationale t

  2026-07-09

  This in-depth article explores Triacetin’s mechanistic roles in metabolic and oncology research, synthesizing fresh evidence on anti-adipogenic and antitumor activities. Drawing from both peer-reviewed studies and workflow-driven best practices, it offers translational researchers strategic guidance on leveraging Triacetin for experimental robustness, protocol innovation, and future clinical potential.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-07-09

  Chen et al. conducted a multi-hospital study in Guangdong, China, mapping the prevalence and transmission of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from 2022–2024. Their work elucidates the dominant genetic mechanisms of multidrug resistance and highlights the efficiency of both horizontal and vertical gene transfer, informing future surveillance and experimental designs.

• BGJ398 (NVP-BGJ398): Selective FGFR Inhibition in Oncology R

  2026-07-08

  BGJ398 (NVP-BGJ398) is a potent, selective small-molecule inhibitor of FGFR1–3, widely used in FGFR-driven malignancies research. Its nanomolar potency and specificity enable precise modulation of FGFR signaling pathways in oncology and developmental biology. This article details its mechanism, evidence base, and critical protocol considerations.

• Bay 11-7821 (BAY 11-7082) in Cancer and Inflammatory Pathway

  2026-07-08

  Bay 11-7821 (BAY 11-7082) is a selective IKK inhibitor that empowers robust and reproducible workflows for dissecting NF-κB-driven signaling in cancer and inflammation studies. This guide details optimized experimental protocols, troubleshooting strategies, and translational applications inspired by the latest immuno-oncology findings.

• MLN4924 HCl Salt: Decoding Neddylation in Viral Immunity

  2026-07-07

  This thought-leadership article explores how MLN4924 HCl salt, a potent NEDD8-activating enzyme inhibitor, enables translational researchers to dissect viral immune evasion, specifically through cullin-RING ligase and ubiquitin-proteasome pathway manipulation. Integrating recent mechanistic findings on RIPK3 degradation by orthopoxviruses, we provide a strategic guide to protocol design, competitive landscape, and future directions for targeting neddylation in cancer and antiviral research.

• TMEM16F in Kupffer Cells Suppresses Liver Injury in Listeria

  2026-07-07

  This study reveals that TMEM16F, a lipid scramblase, is essential in Kupffer cells for protecting the liver from Listeria monocytogenes-induced inflammation and metabolic disruption. By using cell type-specific knockout models, the research uncovers how TMEM16F-mediated membrane repair in liver macrophages limits cell death and tissue damage, providing mechanistic insights with implications for necroptosis and programmed necrotic cell death research.

• cgSHAPE-seq Maps RNA-Degrading Chimera Sites in SARS-CoV-2 5

  2026-07-06

  This study introduces cgSHAPE-seq, a chemical-guided sequencing method that precisely identifies the binding sites of small molecules on structured viral RNA. By mapping how coumarin-based chimeras target the SARS-CoV-2 5’ untranslated region, the work enables rational design of RNA-targeting antivirals and advances molecular tools for studying RNA–ligand interactions.

• BI 2536: Revealing PLK1 Checkpoint Control for Cancer Resear

  2026-07-06

  Explore how BI 2536, a potent PLK1 inhibitor, uniquely elucidates mitotic checkpoint regulation and advances cancer research. This article offers a deep dive into the molecular mechanisms and practical assay implications that set BI 2536 apart.

• 3-Aminobenzamide (PARP-IN-1): Applied Workflows & Experiment

  2026-07-05

  3-Aminobenzamide (PARP-IN-1) empowers researchers to dissect poly (ADP-ribose) polymerase pathways with reliable, low-toxicity inhibition at nanomolar concentrations. This guide bridges cardiovascular, metabolic, and host-pathogen research, offering stepwise protocols, troubleshooting, and data-backed insights for maximizing reproducibility and biological relevance.

• Multiplexed ACE2 Libraries Reveal SARS-CoV-2 Variant Recepto

  2026-07-04

  This study introduces a high-throughput pseudotyped virus assay to systematically map how SARS-CoV-2 spike variants interact with a diverse set of ACE2 receptor variants. The findings illuminate how viral evolution subtly alters compatibility with human ACE2 while more dramatically expanding cross-species receptor usage, informing both virology and host-range research.

• Ciprofloxacin Hydrochloride: Advanced Workflows & Antiparasi

  2026-07-03

  Ciprofloxacin hydrochloride, a fluoroquinolone antibiotic, is redefining experimental design by bridging robust antibacterial mechanisms with emerging antiparasitic workflows. Recent studies and workflow innovations enable researchers to leverage its DNA replication inhibition and immunomodulatory properties, offering unique troubleshooting paths for both classic and translational applications.

443 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page